This study focuses on the comparative in vitro cytotoxicity of chelidonine and homochelidonine on human cancer and non-cancer cells. Both alkaloids produced a decrease in cellular growth in a dose-dependent manner exhibiting greater potency in cancer cells. The growth inhibitory effect was evidenced in both ovarian carcinoma A2780 and lung fibroblast MRC-5 cells by inducing G2 and mitotic phase cell cycle arrest. Results indicated that the extent of apoptosis induced by chelidonine and homochelidonine was correlated to sensitivity to the antiproliferative activity of the evaluated compounds. Western blotting suggested that the cellular toxicological mechanism of chelidonine is related to the differential upregulation of phospho-Chk2, p21Cip1/Waf1, phospho-ERK1/2 and phospho-p38 in various cell types, leading to alternations in the suppression of proliferation and either induction or prevention of apoptosis. Chelidonine showed the more potent effects and also affected the cell cycle checkpoints and MAPK signaling pathways within cells.
GilcaM, GamanL, PanaitE, StoianI, AtanasiuV. (2010) Chelidonium majus-an integrative review: traditional knowledge versus modern findings. Forschende Komplementärmedizin, 17, 241–248.
2.
LeeYC, KimSH, RohSS, ChoiHY, SeoYB. (2007) Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice. Journal of Ethnopharmacology, 112, 40–48
3.
NiederauC, GöpfertE. (1999) The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study. Medizinische Klinik (Munich), 94, 425–430
4.
HavelekR, SeifrtovaM, KralovecK, KrocovaE, TejkalovaV, NovotnyI, CahlikovaL, SafratovaM, OpletalL, BilkovaZ, VavrovaJ, RezacovaM. (2016) Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells. Phytomedicine, 23, 253–266
5.
NadovaS, MiadokovaE, AlfoldiovaL, KopaskovaM, HasplovaK, HudecovaA, VaculcikovaD, GreganF, CipakL. (2008) Potential antioxidant activity, cytotoxic and apoptosis-inducing effects of Chelidonium majus L. extract on leukemia cells. Neuro Endocrinology Letters, 29, 649–652
6.
KimDS, KimSJ, KimMC, JeonYD, UmJY, HongSH. (2012) The therapeutic effect of chelidonic acid on ulcerative colitis. Biological and Pharmaceutical Bulletin, 35, 666–671
MitraS, SurRK, RoyA, MukherjeeAS. (1996) Effect of Chelidonium majus L. on experimental hepatic tissue injury. Phytotherapy Research, 10, 354–356
9.
BiswasSJ, BhattacharjeeN, Khuda-BukhshAR. (2008) Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food and Chemical Toxicology, 46, 1474–1487.
10.
GañánNA, DiasAMA, BombaldiF, ZygadloJA, BrignoleEA, de SousaHC, BragaMEM. (2016) Alkaloids from Chelidonium majus L.: Fractionated supercritical CO2 extraction with co-solvents. Separation and Purification Technology, 165, 199–207.
11.
SuchomelováJ, BochorákováH, PaulováH, MusilP, TáborskáE. (2007) HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family Papaveraceae. Journal of Pharmaceutical and Biomedical Analysis, 44, 283–287.
12.
HădărugăDI, HădărugăNG. (2009). Antioxidant activity of Chelidonium majus L. extracts from the Banat county. Journal of Agroalimentary Processes and Technologies, 15, 396–402
13.
MajiAK, BanerjiP. (2015) Chelidonium majus L. (Greater celandine) - A review on its phytochemical and therapeutic perspectives. International Journal of Herbal Medicine, 3, 10–27.
14.
HeinleH, HagelauerD, PaschtU, KelberO, WeiserD. (2006). Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. Phytomedicine, 13, 75–79.
15.
BrownAC. (2016). Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 6. Food and Chemical Toxicology, S0278–6915, 30221–30226.
16.
ColomboML, BosisioE. (1996) Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research, 33, 127–134.
17.
NoureiniSK, EsmailiH. (2014). Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line. Chemico-Biological Interactions, 5, 141–149.
18.
CapistranoIR, WoutersA, LardonF, GravekampC, ApersS, PietersL. (2015) In vitro and in vivo investigations on the antitumour activity of Chelidonium majus. Phytomedicine, 22, 1279–1287.
19.
KumarGS, HazraS. (2014) Sanguinarine, a promising anticancer therapeutic: photochemical and nucleic acid binding properties. RSC Advances, 4, 56518–56531
20.
VrbaJ, DolezelP, VicarJ, ModrianskýM, UlrichováJ. (2008) Chelerythrine and dihydrochelerythrine induce G1 phase arrest and bimodal cell death in human leukemia HL-60 cells. Toxicology in Vitro, 22, 1008–1017
21.
BanerjeeA, SanyalS, DuttaS, ChakrabortyP, DasPP, JanaK, VasudevanM, DasC, DasguptaD. (2016) The plant alkaloid chelerythrine binds to chromatin, alters H3K9Ac and modulates global gene expression. Journal of Biomolecular Structure & Dynamics, 5, 1–9.
22.
MazzantiG, Di SottoA, FranchittoA, MammolaCL, MarianiP, MastrangeloS, Menniti-IppolitoF, VitaloneA. (2009) Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment. Journal of Ethnopharmacology, 126, 518–524.
23.
DeljaninM, NikolicM, BaskicD, TodorovicD, DjurdjevicP, ZaricM, StankovicM, TodorovicM, AvramovicD, PopovicS. (2016) Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines. Journal of Ethnopharmacology, 190, 362–371.
24.
PanzerA, JoubertAM., BianchiPC, HamelE, SeegersJC. (2001) The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways. European Journal of Cell Biology, 80, 111–118
25.
WangX, TanakaM, KrstinS, PeixotoHS, WinkM. (2016) The interference of selected cytotoxic alkaloids with the cytoskeleton: An insight into their modes of action. Molecules, 21, 1–22.
26.
QazzazME, RajaVJ, LimKH, KamTS, LeeJB, GershkovichP, BradshawTD. (2016) In vitro anticancer properties and biological evaluation of novel natural alkaloid jerantinine B. Cancer Letters, 370, 185–197.
27.
MjelleR, HegreSA, AasPA, SlupphaugG, DrabløsF, SaetromP, KrokanHE. (2015) Cell cycle regulation of human DNA repair and chromatin remodeling genes. DNA Repair, 30, 53–67.
28.
El-ReadiMZ, EidS, AshourML, TahraniA, WinkM. (2013) Modulation of multidrug resistance in cancer cells by chelidonine and Chelidonium majus alkaloids. Phytomedicine, 20, 282–294.
29.
MoudiM, GoR, YienCY, NazreM. (2013) Vinca alkaloids. International Journal of Preventive Medicine, 4, 1231–1235.
30.
PatilM, PablaN, DongZ. (2013) Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cellular and Molecular Life Sciences, 70, 4009–4021
31.
ZanniniL, DeliaD, BuscemiG. (2014) CHK2 kinase in the DNA damage response and beyond. Journal of Molecular Cell Biology, 6, 442–457.
32.
TuWZ, LiB, HuangB, WangY, LiuXD, GuanH, ZhangSM, TangY, RangWQ., ZhouPK. (2013) γH2AX foci formation in the absence of DNA damage: mitotic H2AX phosphorylation is mediated by the DNA-PKcs/CHK2 pathway. FEBS Letters, 587, 3437–3443.
33.
AbbasT, DuttaA. (2009) p21 in cancer: intricate networks and multiple activities. Nature Reviews Cancer, 9, 400–414.
34.
YoshidaM, MatsuiY, IizukaA, IkarashiY. (2009) G2-phase arrest through p21(WAF1 / Cip1) induction and cdc2 repression by gnidimacrin in human hepatoma HLE cells. Anticancer Research, 29, 1349–1354.
35.
MunshiA, RameshR. (2013) Mitogen-activated protein kinases and their role in radiation response. Genes & Cancer, 4, 401–408.
36.
KhalilN, XuYD, O'ConnorR, DuronioV. (2005) Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. The Journal of Biological Chemistry, 280, 43000–43009
37.
LuZ, XuS. (2006) ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life, 58, 621–631.
38.
TangD, WuD, HiraoA, LahtiJM, LiuL, MazzaB, KiddVJ, MakTW, IngramAJ. (2002). ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. The Journal of Biological Chemistry, 277, 12710–12717.
39.
HavelekR, SimanP, CmielovaJ, StoklasovaA, VavrovaJ, VinklarekJ, KnizekJ, RezacovaM. (2012). Differences in vanadocene dichloride and cisplatin effect on MOLT-4 leukemia and human peripheral blood mononuclear cells. Medicinal Chemistry, 8, 615–62.
